Understanding the Importance of Capsules in Dry Powder Inhalers [PDF]
Pharmaceutics, 2021 Pulmonary drug delivery is currently the focus of research and development because of its potential to produce maximum therapeutic benefit to patients by directing the drug straight to the lung disease site.
Francesca Buttini +3 more
doaj +2 more sources
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives [PDF]
Pharmaceutics, 2021 During the last decades, the term “drug delivery systems” (DDSs) has almost fully replaced previously used terms, such as “dosage forms”, in an attempt to emphasize the importance of the drug carrier in ensuring the claimed safety and effectiveness of ...
Styliani Xiroudaki +3 more
doaj +2 more sources
Dry Powder Inhalers for Delivery of Synthetic Biomolecules [PDF]
PharmaceuticalsThis manuscript provides a comprehensive review of advancements in dry powder inhaler (DPI) technology for pulmonary and systemic drug delivery, focusing on proteins, peptides, nucleic acids, and small molecules.
Hossein Omidian +2 more
doaj +2 more sources
The comparative effectiveness and safety of fluticasone-salmeterol via metered-dose versus dry powder inhalers for COPD: A new user cohort study. [PDF]
PLoS MedicineBackgroundFluticasone-salmeterol is available in both metered-dose and dry powder inhaler formulations for the treatment of chronic obstructive pulmonary disease (COPD).
Brandon J Demkowicz +4 more
doaj +2 more sources
A Quality by Design Framework for Capsule-Based Dry Powder Inhalers [PDF]
Pharmaceutics, 2021 Capsule-based dry powder inhalers (cDPIs) are widely utilized in the delivery of pharmaceutical powders to the lungs. In these systems, the fundamental nature of the interactions between the drug/formulation powder, the capsules, the inhaler device, and ...
Li Ding +6 more
doaj +2 more sources
An Audio-Based Method for Assessing Proper Usage of Dry Powder Inhalers [PDF]
Applied Sciences, 2020 Critical technique errors are very often performed by patients in the use of Dry Powder Inhalers (DPIs) resulting in a reduction of the clinical efficiency of such medication.
Athina-Chara Eleftheriadou +4 more
doaj +2 more sources
Patients’ usability of seven most used dry-powder inhalers in COPD [PDF]
Multidisciplinary Respiratory Medicine, 2019 Introduction Inhalation devices affect both the effectiveness and the therapeutic outcomes in persistent airway obstruction, and the effects are largely independent of the drug(s) assumed.
Roberto W. Dal Negro +2 more
doaj +2 more sources
Ciprofloxacin dry powder inhaler in cystic fibrosis [PDF]
BMJ Open Respiratory Research, 2016 Inhaled antibiotics are the backbone of care for people with cystic fibrosis (CF) who have lung infection due to Pseudomonas aeruginosa. They have significantly contributed to the improved quality of life (QOL) and increased survival in people with this disease.1 The systematic application of antibiotic eradication therapy for new or recurrent ...
J.S. Elborn
openaire +3 more sources
Investigation of potential substandard dry powder inhalers on EU and North African markets - evaluation of the delivered and fine particle doses. [PDF]
J Drug Assess, 2022 Zhang Y, Hubert P, Hubert C.
europepmc +3 more sources
An analysis of inhalation technique errors in metered-dose inhaler and dry powder inhaler users
International Journal of Science Annals, 2023 Background and Aim of Study: Decreased efficacy of metered dose inhaler and dry powder inhalers are associated with errors in inhalational techniques.
K. Chaudhary, A. Kumar
doaj +1 more source